Cells’ Response to SARS-CoV-2 Different from Flu, RSV
Cells’ Response to SARS-CoV-2 Different from Flu, RSV
The host transcriptional signature elicited by the coronavirus appears to be less robust and lacks the induction of key antiviral genes.
Cells’ Response to SARS-CoV-2 Different from Flu, RSV
Cells’ Response to SARS-CoV-2 Different from Flu, RSV

The host transcriptional signature elicited by the coronavirus appears to be less robust and lacks the induction of key antiviral genes.

The host transcriptional signature elicited by the coronavirus appears to be less robust and lacks the induction of key antiviral genes.

respiratory syncytial virus
b cell crispr immunity rsv respiratory syncitial virus
CRISPRed B Cells Produce Antibodies Against Hard-to-Treat Viruses
Katarina Zimmer | May 17, 2019
In line with previous research, a new study in mice demonstrates that B cells can be engineered to ward off infections, this time against respiratory syncytial virus (RSV).